Vivoryon Therapeutics AG had a revenue of 0.00 in the quarter ending Jun 30, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2024, Vivoryon Therapeutics AG had annual revenue of 0.00 with 100.00% growth.